Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 3
1967 4
1968 5
1969 4
1970 2
1971 4
1972 8
1973 8
1974 7
1975 6
1976 6
1977 5
1978 3
1979 3
1980 2
1981 2
1982 7
1983 6
1984 3
1985 5
1986 10
1987 9
1988 15
1989 18
1990 23
1991 22
1992 34
1993 37
1994 39
1995 37
1996 45
1997 40
1998 59
1999 62
2000 78
2001 86
2002 70
2003 97
2004 124
2005 127
2006 133
2007 156
2008 190
2009 223
2010 257
2011 298
2012 356
2013 397
2014 481
2015 489
2016 484
2017 467
2018 484
2019 447
2020 524
2021 523
2022 526
2023 502
2024 404
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,508 results

Results by year

Filters applied: . Clear all
Page 1
The Modern Epidemic of Autoimmunity.
Zheng JF, Lee YH, Leong PY. Zheng JF, et al. Among authors: lee yh. Int J Rheum Dis. 2024 Nov;27(11):e15426. doi: 10.1111/1756-185X.15426. Int J Rheum Dis. 2024. PMID: 39584539 Review.
Implications of Microorganisms in Alzheimer's Disease.
Yadav P, Lee YH, Panday H, Kant S, Bajwa N, Parashar R, Jha SK, Jha NK, Nand P, Lee SS, Jha AK. Yadav P, et al. Among authors: lee yh. Curr Issues Mol Biol. 2022 Sep 30;44(10):4584-4615. doi: 10.3390/cimb44100314. Curr Issues Mol Biol. 2022. PMID: 36286029 Free PMC article. Review.
Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study.
Zhang Y, Patel RP, Kim KH, Cho H, Jo JC, Jeong SH, Oh SY, Choi YS, Kim SH, Lee JH, Angelos M, Guruprasad P, Cohen I, Ugwuanyi O, Lee YG, Pajarillo R, Cho JH, Carturan A, Paruzzo L, Ghilardi G, Wang M, Kim S, Kim SM, Lee HJ, Park JH, Cui L, Lee TB, Hwang IS, Lee YH, Lee YJ, Porazzi P, Liu D, Lee Y, Kim JH, Lee JS, Yoon DH, Chung J, Ruella M. Zhang Y, et al. Among authors: lee yh. Mol Cancer. 2023 Dec 9;22(1):200. doi: 10.1186/s12943-023-01886-9. Mol Cancer. 2023. PMID: 38066564 Free PMC article.
Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial.
Kim NH, Moon JS, Lee YH, Cho HC, Kwak SH, Lim S, Moon MK, Kim DL, Kim TH, Ko E, Lee J, Kim SG. Kim NH, et al. Among authors: lee yh. Diabetes Obes Metab. 2024 Sep;26(9):3642-3652. doi: 10.1111/dom.15705. Epub 2024 Jun 10. Diabetes Obes Metab. 2024. PMID: 38853720 Clinical Trial.
7,508 results